Length of Tumour Feeding Artery After Colon Cancer Surgery

NCT02164149 | Unknown

• 1 other identifier: CT121177
• Study Type: observational
• Target: 65
• Locations: 1 country
• Sites: 1

Brief Summary

The quality of colon cancer surgery is highly debated these years since the mortality of the disease is not declining markedly. Surgery is the main treatment of colon cancer and during surgery it is very important for the surgeon to remove the tumour and all potential ways of tumour spread. As colon cancer first of all spreads to the nearby lymph nodes lying along the tumour feeding artery the surgeon aims to cut the vessel as central as possible. This means that all of the tumour feeding artery should have been removed after surgery. In this study the investigators want to measure the length of the tumour feeding artery after surgery as a quality control of the surgery. The investigators hypothesize that the artery will be shorter than 5 mm. The investigators wish to CT scan all patients two days after colon cancer surgery and afterwards measure then length of the artery on the images. This study will not inflict with the normal routine for patient information and treatment.

Conditions

Colon Cancer

Keywords

Colon cancer; Quality of surgery; Length of tumour feeding artery

Outcome Measures

Primary Outcomes (1)

• CT scan after colon cancer surgery. The length of the tumour feeding artery will be measured on the images.

  Patients will have an extra CT scan two days after surgery.

  6 to 9 months

Study Arms (1)

Quality of colon cancer surgery

Patients with primary colon cancer

Other: Patients with primary colon cancer

Interventions

Patients with primary colon cancer OTHER

CT scan two days after surgery

Quality of colon cancer surgery

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients over 18 years with primary colon cancer, who are to have surgery at Randers Regional Hospital, Denmark.

You may qualify if:

• Primary colon cancer

You may not qualify if:

• Kidney failure, allergy to contrast, pregnancy

Sponsors & Collaborators

• University of Aarhus: lead

Study Sites (1)

Aarhus University Hospital

Aarhus, 8000, Denmark

RECRUITING

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal Neoplasms; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases

Study Officials

• Soren Laurberg, Professor

  Aarhus University Hospital

  STUDY DIRECTOR

Central Study Contacts

Ditte Munkedal, MD

CONTACT

+45 7846 7710; Ditte.Munkedal@viborg.rm.dk

Soren Laurberg, Professor

CONTACT

+45 7846 7715; soeren.laurberg@aarhus.rm.dk

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 2, 2014
• First Posted: June 16, 2014
• Study Start: May 1, 2014
• Primary Completion: November 1, 2014
• Study Completion: November 1, 2015
• Last Updated: June 16, 2014

Record last verified: 2014-06

Locations

DK (1)